References
- Argentine, M. D.; Owens, P. K.; Olsen, B. A. Adv. Drug Deliv. Rev. 2007, 59, 12. https://doi.org/10.1016/j.addr.2006.10.005
- International Conference on Harmonisation (ICH) Guidelines, Q3A(R): Impurities in New Drug Substances (Revised Guideline), February 2002.
- International Conference on Harmonisation (ICH) Guidelines, Q3B(R): Impurities in New Drug Products (Revised Guideline), February 2003.
- International Conference on Harmonisation (ICH) Guidelines, Q3C and Q3C(M): Impurities: Guideline for Residual Solvents, July 1997 and September 2002, respectively.
- Ahuja, S., Alsante, K., Eds.; Handbook of Isolation and Characterization of Impurities in Pharmaceuticals; Academic Press: Amsterdam, 2003; Vol. 5.
- Gorog, S., Ed.; Identification and Determination of Impurities in Drugs; Elsevier: Amsterdam, 2000; Vol. 4.
- Shioya, H.; Shimojo, M.; Kawahara, Y. J. Chromatogr. 1989, 496, 129. https://doi.org/10.1016/S0378-4347(00)82559-1
Cited by
- ) complexes: luminescent probes and sensors for G-quadruplex DNA and endoplasmic reticulum imaging vol.41, pp.1, 2017, https://doi.org/10.1039/C6NJ02890J